SEC 13F Intelligence

Highvista Strategies LLC / PACB

Highvista Strategies LLC’s Pacific Biosciences Calif In Position

Does Highvista Strategies LLC own Pacific Biosciences Calif In (PACB)? Not currently — the last reported position was 378.5K shares worth $2M in Q4 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q4 2019
Shares
378.5K
% of Portfolio
+1.48%
Quarters Held
4
position exited

Position History PACB

Reported value by quarter
Q1 ’19: $3MQ1 ’19Q2 ’19: $2MQ2 ’19Q3 ’19: $2MQ3 ’19Q4 ’19: $2MQ4 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2019378.5K$2M+1.48%
Q3 2019378.5K$2M+1.33%
Q2 2019378.5K$2M+1.17%
Q1 2019378.5K$3M+2.23%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of PACB.